Position history for UBS Group AG's holdings in SUMMIT THERAPEUTICS INC
UBS Group AG holds 3.7M shares of SMMT (SUMMIT THERAPEUTICS INC), worth $69.8M as of 2026-Q1. The position was increased (+322.7% shares). SMMT represents 0.0% of UBS Group AG's portfolio.
Current Value
$69.8M
Current Shares
3.7M
Total Value Change
+$68.5M
Total Shares Change
+3.5M
Other major holders of SMMT: BAKER BROS. ADVISORS LP
Increased |
| 3.7M |
+322.7% |
| $69.8M |
| 0.0% |
| $15.11 |
48 |
| 2025-Q4 | Decreased | 870,719 | -31.9% | $15.2M | 0.0% | $17.49 | 0 |
| 2025-Q3 | Decreased | 1.3M | -38.9% | $26.4M | 0.0% | $21.16 | 0 |
| 2025-Q2 | Increased | 2.1M | +65.6% | $44.6M | 0.0% | $20.60 | 43 |
| 2025-Q1 | Increased | 1.3M | +6.6% | $24.4M | 0.0% | $20.32 | 31 |
| 2024-Q4 | Increased | 1.2M | +890.1% | $21.2M | 0.0% | $17.89 | 46 |
| 2024-Q3 | Decreased | 119,819 | -28.6% | $2.6M | 0.0% | $20.89 | 0 |
| 2024-Q2 | Decreased | 167,867 | -64.8% | $1.3M | 0.0% | $7.80 | 0 |